Credit Suisse’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
$13.7M Sell
973,484
-290,641
-23% -$4.1M 0.01% 778
2023
Q4
$13.2M Buy
1,264,125
+48,930
+4% +$511K 0.01% 795
2023
Q3
$12.4M Sell
1,215,195
-247,249
-17% -$2.53M 0.01% 807
2023
Q2
$11M Sell
1,462,444
-175,473
-11% -$1.32M 0.01% 869
2023
Q1
$14.5M Sell
1,637,917
-4,170,063
-72% -$36.9M 0.01% 776
2022
Q4
$53M Sell
5,807,980
-1,610,942
-22% -$14.7M 0.06% 367
2022
Q3
$59.9M Buy
7,418,922
+524,548
+8% +$4.23M 0.07% 308
2022
Q2
$51.8M Buy
6,894,374
+137,322
+2% +$1.03M 0.05% 366
2022
Q1
$63.4M Sell
6,757,052
-89,830
-1% -$843K 0.05% 361
2021
Q4
$54.8M Sell
6,846,882
-196,733
-3% -$1.58M 0.03% 427
2021
Q3
$68.6M Sell
7,043,615
-103,935
-1% -$1.01M 0.04% 369
2021
Q2
$71.7M Buy
7,147,550
+2,780,234
+64% +$27.9M 0.04% 374
2021
Q1
$50.4M Sell
4,367,316
-2,580,276
-37% -$29.8M 0.03% 519
2020
Q4
$67M Sell
6,947,592
-1,440,130
-17% -$13.9M 0.03% 401
2020
Q3
$75.6M Buy
8,387,722
+366,320
+5% +$3.3M 0.05% 307
2020
Q2
$98.9M Sell
8,021,402
-330,513
-4% -$4.08M 0.07% 226
2020
Q1
$75M Buy
8,351,915
+1,500,345
+22% +$13.5M 0.06% 241
2019
Q4
$67.1M Sell
6,851,570
-4,040,590
-37% -$39.6M 0.05% 318
2019
Q3
$74.9M Buy
10,892,160
+3,719,394
+52% +$25.6M 0.06% 241
2019
Q2
$66.2M Buy
7,172,766
+4,029,506
+128% +$37.2M 0.06% 260
2019
Q1
$49.3M Buy
3,143,260
+1,628,404
+107% +$25.5M 0.05% 339
2018
Q4
$23.4M Sell
1,514,856
-826,456
-35% -$12.7M 0.02% 581
2018
Q3
$50.4M Sell
2,341,312
-995,600
-30% -$21.4M 0.05% 356
2018
Q2
$81.2M Buy
3,336,912
+383,166
+13% +$9.32M 0.08% 200
2018
Q1
$50.5M Buy
2,953,746
+500,845
+20% +$8.56M 0.05% 353
2017
Q4
$46.5M Buy
2,452,901
+1,124,102
+85% +$21.3M 0.04% 368
2017
Q3
$23.4M Buy
1,328,799
+181,496
+16% +$3.19M 0.02% 589
2017
Q2
$38.1M Buy
1,147,303
+78,683
+7% +$2.61M 0.04% 425
2017
Q1
$34.3M Buy
1,068,620
+40,358
+4% +$1.3M 0.03% 485
2016
Q4
$37.3M Buy
1,028,262
+694,678
+208% +$25.2M 0.04% 454
2016
Q3
$15.3M Sell
333,584
-390,011
-54% -$17.9M 0.01% 843
2016
Q2
$36.3M Buy
723,595
+431,760
+148% +$21.7M 0.04% 450
2016
Q1
$15.6M Sell
291,835
-396,566
-58% -$21.2M 0.02% 781
2015
Q4
$45.2M Sell
688,401
-174,982
-20% -$11.5M 0.05% 394
2015
Q3
$48.7M Buy
863,383
+140,792
+19% +$7.95M 0.06% 343
2015
Q2
$42.7M Sell
722,591
-327,837
-31% -$19.4M 0.04% 451
2015
Q1
$65.4M Sell
1,050,428
-114,316
-10% -$7.12M 0.07% 281
2014
Q4
$67M Sell
1,164,744
-883,043
-43% -$50.8M 0.06% 304
2014
Q3
$110M Buy
2,047,787
+440,053
+27% +$23.7M 0.09% 196
2014
Q2
$84.3M Buy
1,607,734
+47,200
+3% +$2.47M 0.07% 236
2014
Q1
$82.5M Buy
1,560,534
+520,565
+50% +$27.5M 0.08% 221
2013
Q4
$41.7M Buy
1,039,969
+613,937
+144% +$24.6M 0.04% 424
2013
Q3
$16.1M Sell
426,032
-355,185
-45% -$13.4M 0.02% 721
2013
Q2
$30.6M Buy
+781,217
New +$30.6M 0.03% 483